Evidence map›Paper›PMID 32674331›Full record

ArticleBiomedicines2020

Reactive Metamizole Metabolites Enhance the Toxicity of Hemin on the ATP Pool in HL60 Cells by Inhibition of Glycolysis.

Deborah Rudin, Maurice Schmutz, Noëmi Johanna Roos, Jamal Bouitbir, Stephan Krähenbühl

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Deborah RudinDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.ORCID 0000-0003-3069-9732
Maurice SchmutzDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Noëmi Johanna RoosDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Jamal BouitbirDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.ORCID 0000-0003-4453-9457
Stephan KrähenbühlDivision of Clinical Pharmacology & Toxicology, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland.ORCID 0000-0001-8347-4145
University of Basel · CHUniversity Hospital of Basel · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung SNF 31003A_160206
6 · The paper itself

Abstract

Metamizole is an analgesic, whose pharmacological and toxicological properties are attributed to N-methyl-aminoantipyrine (MAA), its major metabolite. In the presence of heme iron, MAA forms reactive metabolites, which are toxic for granulocyte precursors. Since decreased cellular ATP is characteristic for MAA-associated toxicity, we studied the effect of MAA with and without hemin on energy metabolism of HL60 cells, a granulocyte precursor cell line. The combination MAA/hemin depleted the cellular ATP stronger than hemin alone, whereas MAA alone was not toxic. This decrease in cellular ATP was observed before plasma membrane integrity impairment. MAA/hemin and hemin did not affect the proton leak but increased the maximal oxygen consumption by HL60 cells. This effect was reversed by addition of the radical scavenger

Indexed as

agranulocytosisglycolysismechanismmetamizolemitochondria

Identifiers

PMID32674331
PMCPMC7400389
OpenAlexW3042468565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.